SERIES B PREFERRED STOCK PURCHASE AGREEMENTSeries B Preferred • June 18th, 2010 • Activecare, Inc. • Communications equipment, nec • Delaware
VISTA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the investors listed on Exhibit A attached hereto (each a “Purchaser” and together the “Purchasers”), agree as follows:
SERIES B PREFERRED STOCK PURCHASE AGREEMENT among KIROMIC, INC. a Delaware corporation and THE INVESTORS NAMED IN EXHIBIT A dated as of September 7, 2019Series B Preferred • April 8th, 2020 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SERIES B PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of the day of , 2019 by and among Kiromic, Inc., a Delaware corporation (the “Company”), the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
SERIES B PREFERRED STOCK PURCHASE AGREEMENT Dated as of March 29, 2010 by and among GLOWPOINT, INC. and THE PURCHASERS LISTED ON EXHIBIT ASeries B Preferred • March 30th, 2010 • Glowpoint Inc • Telephone communications (no radiotelephone) • New York
This SERIES B PREFERRED STOCK PURCHASE AGREEMENT dated as of March 29, 2010 (this “Agreement”) by and among Glowpoint, Inc., a Delaware corporation (the "Company"), and each of the purchasers of the Company’s Series B Convertible Preferred Stock whose names are set forth on Exhibit A attached hereto (each a "Purchaser" and collectively, the "Purchasers").
